Sagent Launches Atracurium Besylate Injection

Sagent Pharmaceuticals announced the launch of Atracurium Besylate Injection, the generic form of the neuromuscular blocker Tracrium, in 50 mg per 5mL latex-free vials.

Atracurium Besylate Injection is a nondepolarizing skeletal muscle relaxant. It is indicated as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

For more information call (866) 625-1618 or visit www.sagentpharma.com.